In a blinded extension among participants with baseline BMI 35, weight loss continued through 104 weeks, reaching a mean of 30.3% [1][2]
These signs, especially several together on a hot day, are different, and they mean act now: Dizziness or lightheadedness when you stand up A rapid or pounding heartbeat Dark, strong-smelling urine, or passing very little Muscle cramps Confusion or trouble concentrating Suddenly stopping sweating despite the heat That last one matters most
It is safer to use one vial at a time and reconstitute new vials at your preferred concentration rather than trying to mix concentrations mid-treatment
Glucagon-like peptide-1 (GLP-1) receptor agonists, including semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), and liraglutide (Victoza, Saxenda), are injectable biological medicines used for type 2 diabetes and weight management